PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 158 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $414,000 | -25.4% | 109,938 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $555,000 | -22.1% | 109,938 | -5.0% | 0.00% | -50.0% |
| Q2 2019 | $712,000 | +32.3% | 115,665 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $538,000 | +20.4% | 115,665 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $447,000 | -27.8% | 115,665 | +16.9% | 0.00% | 0.0% |
| Q3 2018 | $619,000 | -22.1% | 98,958 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $795,000 | +8.0% | 98,958 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $736,000 | +25.4% | 98,958 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $587,000 | -18.7% | 98,958 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $722,000 | -0.8% | 98,958 | -7.8% | 0.00% | 0.0% |
| Q2 2017 | $728,000 | -23.2% | 107,358 | +6.8% | 0.00% | -33.3% |
| Q1 2017 | $948,000 | +794.3% | 100,558 | +724.2% | 0.00% | – |
| Q4 2016 | $106,000 | -31.2% | 12,200 | -50.0% | 0.00% | – |
| Q3 2016 | $154,000 | +202.0% | 24,400 | +100.0% | 0.00% | – |
| Q2 2016 | $51,000 | -3.8% | 12,200 | 0.0% | 0.00% | – |
| Q1 2016 | $53,000 | -29.3% | 12,200 | 0.0% | 0.00% | – |
| Q4 2015 | $75,000 | +7.1% | 12,200 | 0.0% | 0.00% | – |
| Q3 2015 | $70,000 | – | 12,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|